Pneumonia due to chlamydia trachomatis in an immunocompromised adult

The New England Journal of Medicine
J I ItoR E Sobonya


No abstract listed.


Jun 1, 1975·American Journal of Clinical Pathology·F F MacasaetT F Keys
May 19, 1977·The New England Journal of Medicine·G T FrommellJ D Schwartzman
Mar 30, 1978·The New England Journal of Medicine·H R HarrisonE R Alexander
Sep 1, 1978·The Journal of Pediatrics·C ArthJ Schachter
Jun 1, 1966·The American Journal of Medicine·R E Kanich, J E Craighead
Apr 1, 1980·The Journal of Infectious Diseases·C R RinaldoM S Hirsch
Apr 3, 1981·JAMA : the Journal of the American Medical Association·A L KomaroffJ Schachter


Oct 1, 1986·European Journal of Clinical Microbiology·J GrayP A Mårdh
Dec 13, 1984·The New England Journal of Medicine·D I BernsteinM A Lovett
Mar 30, 2002·Transplantation·William M Geisler, Lawrence Corey
Dec 1, 1985·Archives of Disease in Childhood·A A Attenburrow, C M Barker
Jun 20, 1998·Sexually Transmitted Infections·S Edwards, C Carne
Oct 17, 2007·Internal Medicine·Shiro ImokawaKingo Chida
Oct 1, 1985·Journal of the American Geriatrics Society·T J MarrieC Kwan
Mar 23, 1989·The New England Journal of Medicine·F P KroonR van Furth
Jan 1, 1990·Pediatric Pathology·M GriffinW Andrews

Related Concepts

Chlamydia Infections
Chlamydia trachomatis
Cytomegalovirus Infections
Natural Immunosuppression
Experimental Lung Inflammation
Acute Myeloid Leukemia, M1

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.